Keystone Law has advised Clinical Partners Limited on its acquisition of the renowned Oxford ADHD and Autism Centre (“Oxford ADHD”).
Clinical Partners is one of the UK’s largest independent providers of neurodevelopmental and mental health services both for the NHS and private sectors. Currently supporting over 40,000 people annually, the acquisition will allow the business to enhance its capacity to serve as many people as possible.
Oxford ADHD & Autism Centre specialises in diagnosing and supporting children and adults with neurodevelopmental disorders and related conditions. Its 40 specialist staff will join Clinical Partners.
Keystone Law’s corporate partner Dee Sian-Bieleman led the team advising Clinical Partners.
Clinical Partners’ Chief Financial Officer, Michael Denning, said:
“We are delighted to have acquired Oxford ADHD and using our combined experience and expertise to further develop our services for patients and families. The support and advice provided by Dee and the Keystone Law team was invaluable, pragmatic and focussed throughout the acquisition and we very much look forward to working together again in the future.”
Dee Sian-Bieleman said:
“It was an absolute pleasure working with Michael and the team at Clinical Partners. We wish them and Oxford ADHD every success in their growth journey.”
Oxford ADHD was advised by CapEQ (M&A) with legal advice from Freeths.